Catalysts for $JNJ
67 tracked
May 31, 2012
approval
STELARA (USTEKINUMAB) — FDA approval
JOHNSON & JOHNSON
→
May 2, 2012
approval
STELARA (USTEKINUMAB) — FDA approval
JOHNSON & JOHNSON
→
Apr 6, 2012
approval
STELARA (USTEKINUMAB) — FDA approval
JOHNSON & JOHNSON
→
Oct 20, 2010
approval
STELARA (USTEKINUMAB) — FDA approval
JOHNSON & JOHNSON
→
Dec 30, 2009
approval
STELARA (USTEKINUMAB) — FDA approval
JOHNSON & JOHNSON
→
Sep 25, 2009
approval
STELARA (USTEKINUMAB) — FDA approval
JOHNSON & JOHNSON
→
RECRUITING
phase readout
NCT05289687: Daratumumab for Chemotherapy-Refractory Minimal Residual Disease in T Cell ALL
JOHNSON & JOHNSON
→